SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
ELBW 婴儿的表面活性剂气道正压和脉搏血氧饱和度试验
基本信息
- 批准号:7605226
- 负责人:
- 金额:$ 1.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-15 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:Air PressureBronchopulmonary DysplasiaComputer Retrieval of Information on Scientific Projects DatabaseDelivery RoomsEnvironmental air flowFundingGrantIncidenceInfantInstitutionIntratracheal IntubationMechanical ventilationOxygenPremature InfantPulse OximetryPulse PressureResearchResearch PersonnelResourcesRetinopathy of PrematuritySourceUnited States National Institutes of Healthsurfactant
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The investigators hope to determine if the incidence bronchopulmonary dysplasia (BPD) can be reduced in premature infants by using continuous positive air pressure (CPAP) and a permissive ventilation strategy rather than automatic endotracheal intubation, surfactant administration, and conventional mechanical ventilation beginning in the delivery room. They also hope to determine if maintaining a lower oxygen saturation in these infants will reduce the incidence of significant retinopathy of prematurity (ROP).
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID K STEVENSON其他文献
DAVID K STEVENSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID K STEVENSON', 18)}}的其他基金
Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
铬中卟啉预防新生儿黄疸
- 批准号:
7945355 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:
Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
铬中卟啉预防新生儿黄疸
- 批准号:
7778390 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:
Therapeutic Use of Heme Analogs: Absorption in Intestine
血红素类似物的治疗用途:肠道吸收
- 批准号:
7815755 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:
Effects of Statins on Heme Oxygenase-1 Regulation
他汀类药物对血红素加氧酶 1 调节的影响
- 批准号:
7210136 - 财政年份:2007
- 资助金额:
$ 1.05万 - 项目类别:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
ELBW 婴儿的表面活性剂气道正压和脉搏血氧饱和度试验
- 批准号:
7717880 - 财政年份:2007
- 资助金额:
$ 1.05万 - 项目类别:
Effects of Statins on Heme Oxygenase-1 Regulation
他汀类药物对血红素加氧酶 1 调节的影响
- 批准号:
7359601 - 财政年份:2007
- 资助金额:
$ 1.05万 - 项目类别:
相似海外基金
Metabolic mechanisms underlying bronchopulmonary dysplasia-associated pulmonary hypertension
支气管肺发育不良相关肺动脉高压的代谢机制
- 批准号:
10736803 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
Basic research for the development of therapies for bronchopulmonary dysplasia focusing on the IL-33 pathway.
以 IL-33 通路为重点的支气管肺发育不良疗法开发的基础研究。
- 批准号:
23K07250 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants
唾液 miRNA 作为极低胎龄婴儿支气管肺发育不良相关肺动脉高压的预后标志物
- 批准号:
10739639 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
Novel Small Molecule Drug Candidate for the Prevention of Bronchopulmonary Dysplasia
预防支气管肺发育不良的新型小分子候选药物
- 批准号:
10698418 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD)
DLL4 在发育中的肺和支气管肺发育不良 (BPD) 中的作用
- 批准号:
10584811 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
预防高危早产儿支气管肺发育不良的新方法
- 批准号:
10765750 - 财政年份:2023
- 资助金额:
$ 1.05万 - 项目类别:
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
预防高危早产儿支气管肺发育不良的新方法
- 批准号:
10482142 - 财政年份:2022
- 资助金额:
$ 1.05万 - 项目类别:
The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia
IL-33在高氧诱导的新生儿肺损伤和支气管肺发育不良中的作用
- 批准号:
10593394 - 财政年份:2022
- 资助金额:
$ 1.05万 - 项目类别:
The role of IL-33 in hyperoxia-induced neonatal lung injury and bronchopulmonary dysplasia
IL-33在高氧诱导的新生儿肺损伤和支气管肺发育不良中的作用
- 批准号:
10665809 - 财政年份:2022
- 资助金额:
$ 1.05万 - 项目类别: